title: [Drug therapy of chronic venous insufficiency].
abstract: The medicamentous therapy of the chronical venous insufficiency is necessarily symptomatic. The first therapeutical step should be the elimination of the edema. Bioflavonoides inhibit the formation of an edema and possibly protect from its sclerosing effects. Saluretics, however, eliminate preexisting obstructive edemas and are no longer indicated afterwards. The effect can be ameliorated by therapeutics improving the microcirculation. Antiphlogistic agents are indicated for inflammatory conditions. Skin protecting substances can be applied to the suppression of edema. Antieczematous therapeutics can be employed according to the current rules of dermatology.
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002908:Chronic Disease; D004232:Diuretics / Q000627:therapeutic use; D004487:Edema / Q000188:drug therapy / Q000209:etiology; D005419:Flavonoids / Q000627:therapeutic use; D006801:Humans; D014689:Venous Insufficiency / Q000150:complications / Q000188:drug therapy*
chemical_list: D000893:Anti-Inflammatory Agents; D004232:Diuretics; D005419:Flavonoids
vernacular_title: Medikamentöse Therapie der chronischen Veneninsuffizienz.